Passage Bio Inc (NAS:PASG)
$ 0.9072 -0.1028 (-10.18%) Market Cap: 56.04 Mil Enterprise Value: 3.82 Mil PE Ratio: 0 PB Ratio: 0.77 GF Score: 33/100

Q2 2021 Passage Bio Inc Earnings Call Transcript

Aug 05, 2021 / 12:30PM GMT
Release Date Price: $12.64 (+5.77%)
Operator

Good morning, and welcome to the Passage Bio Second Quarter 2021 Financial and Operating Results Conference Call. (Operator Instructions) Please be advised, this call is being recorded at the company's request.

At this time, I would like to turn it over to Stuart Henderson, Vice President of Investor Relations and Strategic Finance. Stuart, please begin.

Stuart M. Henderson
Passage Bio, Inc. - VP IR & Strategic Finance

[Thank you, operator. This morning, we issued a press release that] outlines the topics we plan to discuss today. This release is available on the Passage Bio website at investors.passagebio.com under the Press Releases and Statements section.

On today's call, Bruce Goldsmith, President and Chief Executive Officer, will review our second quarter 2021 financial results and discuss recent business highlights; Eliseo Salinas, our Chief R&D Officer, will review our key clinical updates; and Jill Quigley, our Chief Operating Officer, will also be available for the Q&A portion of the call.

Before we begin,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot